ACOU085: Promising Treatment for Hearing Loss to be Showcased at Upcoming Conferences by Acousia Therapeutics

Acousia Therapeutics GmbH, a clinical stage biotech company located in Tübingen, Germany, will be presenting their latest clinical study at two upcoming conferences in August and September of 2024. The ACOU085 Phase 2 PROHEAR study will be discussed at the HansonWade 4th Inner Ear Disorders Therapeutics Summit in Boston, Massachusetts from August 20-22, and at the 36th World Congress of Audiology…

Source

ACOU085: Promising Treatment for Hearing Loss to be Showcased at Upcoming Conferences by Acousia Therapeutics

Online Ticket Sales for Stirling Highland Games Exceed Expectations

Investment app Gather collapses after failing to repay government loan

Investment app Gather collapses after failing to repay government loan

Gold Prices Rise as the Dollar Slowly Dies

Richard Murphy, The Bank of England, And MMT Confusion

We Can’t Fix International Organizations like the WTO. Abolish Them.

Free Markets Promote Peaceful Cooperation and Racial Harmony

Experts State Bullish Views on Silver But Could It Pass £100?

Ana-Maria Coaching Marks Milestone with New Book Release

New Bonded Warehouse Facilities Launched in Immingham

From Corporate Burnout to High-Performance Coach: Anna Mosley’s Inspiring Journey with ‘Eighty’

What Went Right in 2025 Tech Policy and What an Optimistic Year for Tech Policy Should Focus on in 2026

The Moral Case Against Trump’s Homebuyer Ban

How Securities Regulation Is Holding Back the Smallest Businesses, and How to Fix It

Uber drops 2030 all-electric target as chief executive warns EV shift is stalling

Recent News

What Went Right in 2025 Tech Policy and What an Optimistic Year for Tech Policy Should Focus on in 2026

The Moral Case Against Trump’s Homebuyer Ban

How Securities Regulation Is Holding Back the Smallest Businesses, and How to Fix It

Uber drops 2030 all-electric target as chief executive warns EV shift is stalling